Standard Family Office LLC Seagen Inc. Transaction History

Standard Family Office LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1,196 - $1,972	11 New	11 $2,000
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $2,272 - $2,999	-19 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $2,708 - $3,626	19 New	19 $3,000
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $810 - $966	-6 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$137.51 - $190.8 $137 - $190	-1 Reduced 14.29%	6 $1,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $1,152 - $1,483	7 New	7 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.